Azuma Y, Hirakawa H, Yamashita A, et al (2006) Genome sequence of the Cat Pathogen Chlamydophila felis. DNA Research 13, 15-23.
Becker Y. (1978) The chlamydia: molecular biology of procaryotic obligate parasites of encaryocytes. Microbiol. Rev 42, 274-306
Corsaro D, Venditti D, Valassina M. (2002) New parachlamydial 16S rDNA phylotypes detected in human clinical samples. Res Microbiol. 2002 Nov;153(9):563-7.
Dean R, Harley R, Helps C, Caney S, Gruffydd-Jones T. 2005,Use of quantitative real-time PCR to monitor the response of Chlamydophila felis infection to doxycycline treatment. J Clin Microbiol. 2005 Apr;43(4):1858-64
Di Francesco A, Piva S & Baldelliw R (2004) Prevalence of Chlamydophila felis by PCR among healthy pet cats in Italy. The New Microbiologica 27, 199-202
Everson JS, Garner SA, Lambden PR, Fane BA & Clarke IN (2003) Host range of chlamydiaphages phiCPAR 39 and Chp3. J Bacteriol 185, 6490-6492
Gerhardt N, Schulz BS, Werckenthin C & Hartmann K (2006) Pharmacokinetics of enrofloxacin and its efficacy in comparison wtih doxycline in the treatment of Chlamydophila felis infection in cats with conjunctivitis. Vet Rec 159, 591-594.
Gunn-Moore DA, Werrett G, Harbour DA, Fielden H and Gruffydd-Jones TJ (1995) Prevalance of Chalmydia psittaci antibodies in healthy pet cats in Britain. Vet Rec 136, 366-367
Harley R, Herring A, Egan K, Howard P, Gruffydd-Jones TJ, Azuma Y, Shirai M and Helps C (2007) Molecular characteristics of 12 Chlamydophila felis polymorphic membrane protein genes. Vet Micro 124, 230-238
Hartley JC, Stevenson S, Robinson AJ, Littlewood JD, Carder C, Cartledge J, Clark C, Ridgway GL.2001Conjunctivitis due to Chlamydophila felis (Chlamydia psittaci feline pneumonitis agent) acquired from a cat: case report with molecular characterization of isolates from the patient and cat. J Infect. 2001 Jul;43(1):7-11.
Hartmann AD, Helps CR, Lappin MR, Werckenthin C & Hartmann K (2008) Efficacy of pradofloxacin in cats with feline upper respirtory tract disease due to Chlamydophila felis or Mycoplasma infections. J Vet Intern Med 22, 44-52
Lang GH (1992) Prevalence of antibodies to Coxiela and Chlamydia spp. in cats in Ontario. Can Vet J 33, 134
Longbottom D & Livingstone M (2004) Vaccination against chlamydial infections of man and animals. Vet J 17, 263-275
O’Dair HA, Hopper CD, Gruffydd-Jones TJ, Harbour DA & Waters L (1994) Clinical aspects of Chlamydia psittaci infection in cats infected with feline immunodeficiency virus. Vet Rec 134, 365-368
Sparkes AH, Caney SMA, Sturgess CP & Gruffydd-Jones TJ (1999) The clinical efficacy of topical and systemic therapy for the treatment of of feline ocular chlamydiosis. J Fel Med Surg 1, 31-35
Streeten BW, Streeten EA. "Blue-body" epithelial cell inclusions in conjunctivitis. Ophthalmology. 1985 Apr;92(4):575-9.
Sturgess CP, Gruffydd-Jones TJ, Harbour DA & Jones RL (2001) Controlled study of the efficacy of clavulanic acid-potentiated amoxycillin in the treatment of Chlamydia psittaic in cats. Vet Rec 149, 73-76
Wills JM (1986) Chlamydial infection in the cat. PhD Thesis University of Bristol
Wills JM, Gruffydd-Jones TJ, Richmond SJ, Gaskell RM & Bourne FJ (1987) Effect of vaccination on feline Chalmydia psittaci infection. Infect Immun 55, 253-2657